Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-027979
Filing Date
2013-05-15
Accepted
2013-05-15 16:52:52
Documents
1
Period of Report
2013-05-15

Document Format Files

Seq Description Document Type Size
1 FC OPENMARKETPURCHASE 5-15-13 rrd380073.html 4  
1 FC OPENMARKETPURCHASE 5-15-13 rrd380073.xml 4 3438
  Complete submission text file 0001181431-13-027979.txt   4808
Mailing Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039
Business Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039 9739943999
COLUMBIA LABORATORIES INC (Issuer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 354 EISENHOWER PARKWAY PLAZA I - SECOND FLOOR LIVINGSTON NJ 07039
Business Address
CONDELLA FRANK JR (Reporting) CIK: 0001282199 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10352 | Film No.: 13848057